Small animal imaging is a procedure employed using imaging devices and elements observing biological processes in animals such as rats and mice for drug genetic material expression studies. These devices are comparable to the devices that are used for diagnostic in humans owing to its smaller size, these devices are also referred to as micro devices. Imaging systems are cost-effective for commercialization and steady validation of new drugs as it contains the whole body scan of the animals. The examination provided by using this system can deliver respected information in preclinical or phase I stage of clinical trials and to recognize the activity of pharmaceutical compounds. Small animal imaging is measurement and allocation of biological processes that include the study of the target molecule that is used in clinical research for drug development.
The factors driving the growth of this market are technological advancements such as high-resolution multimodality MRI in the field of small animal imaging and an upsurge in market demand for small animal imaging techniques. Further, increasing number of the pre-clinical research, and growing investments in the development of medicines and are also boosting the growth of this market. Additionally, growing applications of in-vivo imaging in pre-clinical research, increasing number of Pharmaceutical companies and clinical research organizations, and real-time data storage and high-resolution modalities are again some of the key factors that are propelling the growth of the small animal imaging market. On the contrary, insufficient infrastructure provisions for research facilities, and the lack of skilled research staff in developing economies with the prerequisite of high-end devices are the major restraining factors for small animal imaging market.
In terms of geographies, North America has led the growth of this Small animal imaging market followed by Europe. While the Asia Pacific is the fastest growing region in this market. The growth in North America region is due to investments by clinical research organizations in pre-clinical studies, growing number of pharmaceutical and research-based organizations, promising compensation policies by originations and aggregate government funding in research activities are driving the growth in this market. Furthermore, in Europe region factors such as rising amount of research organizations for diagnosis of diseases and increasing investments by pharmaceutical companies in R&D are major factors boosting the growth of the small animal imaging market. Additionally, in the Asia Pacific region, the countries such as India and China are proposing high growth opportunities for the small animal imaging market players, increasing number of translational research activities and growing government support for biotechnology and pharmaceutical R&D are propelling the growth in this market.
iBox® Scientia™ Small Animal Imaging System from Analytik-Jena
October 2016, Analytik-Jena has launched iBox® Scientia™ Small Animal Imaging System. The iBox Scientia featured high sensitivity imaging and accurate quantification of bioluminescent and fluorescent sources. The new BioCam 900 camera provided superior imaging capabilities for bioluminescence. The system was versatile and supported imaging of any probe in the visible to near-infrared (NIR) range. NIR enabled less skin autofluorescence (~650nm) and deep penetration with use of RFP for (3X) 2 penetration depth and GFP, NIR for near (8X) 2 penetration depth. The wide spectrum also allowed more options for multiplex labeling. This capability displayed tissue/tissue interaction, enhanced signal to background ratio and detection of multiple fluorescent proteins or labels.
For More Details@ https://bit.ly/2PKBFxc
Healthcare Journal Blog 